Jerome Wong - 16 Nov 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Chief Financial Officer
Signature
/s/ Brennan Rogers, as Attorney-in-Fact
Issuer symbol
EKSO
Transactions as of
16 Nov 2022
Net transactions value
-$927
Form type
4
Filing time
17 Nov 2022, 16:47:08 UTC
Previous filing
04 Aug 2022
Next filing
15 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Sale $927 -723 -0.71% $1.28* 101,469 16 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person on November 16, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the third installment of a restricted stock award originally reported by the Reporting Person in Form 3 filed with the Commission on June 22, 2022
F2 These shares were sold in a single transaction at a price of $1.2825 per share.